Neuropharmacologic control of neuroendocrine function in man (Q38086139)

28 August 2017

1 reference

title

Neuropharmacologic control of neuroendocrine function in man (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

6 June 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

6 June 2022

author name string

L. A. Frohman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A234567

6 June 2022

M. E. Stachura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A234567

6 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=234567

6 June 2022

publication date

1 February 1975

1 reference

full work available at URL

28 August 2017

24

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0026049575900232?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

https://api.elsevier.com/content/article/PII:0026049575900232?httpAccept=text/plain

6 June 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

6 June 2022

1 reference

28 August 2017

24

1 reference

28 August 2017

2

1 reference

28 August 2017

211-234

1 reference

Growth Hormone Responses to L-Dopa in Depressed Patients

28 August 2017

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.178.4067.1304

Hypothalamic control of adenohypophysial secretions

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

6 June 2022

Human Prolactin

2

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Neural regulation of growth hormone secretion

6 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Nervous control of growth hormone secretion

6 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Hypothalamic regulatory hormones

6 June 2022

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Thyrotropin releasing hormone: secretion and actions

6 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Clinical Neuropharmacology of Hypothalamic Releasing Factors

6 June 2022

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide

6 June 2022

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence

6 June 2022

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

6 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Direct Evaluation of Pituitary Thyrotropin Reserve Utilizing Synthetic Thyrotropin Releasing Hormone1

6 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man

6 June 2022

17

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Increase of Serum Growth Hormone Concentration following Thyrotropin-Releasing Hormone Injection in Patients with Acromegaly or Gigantism

6 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of Synthetic TRF on Hormone Release from Bovine Anterior Pituitaryin Vitro

6 June 2022

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Site of action of vasopressin in causing corticotropin release.

6 June 2022

20

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Pressinoic acid: a peptide with potent corticotrophin-releasing activity.

6 June 2022

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Stimulation of LH Release in Men and Women by LH-Releasing Hormone Purified from Porcine Hypothalami

6 June 2022

22

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Modulation of pituitary gonadotropin response to gonadotropin-releasing hormone by estradiol.

6 June 2022

23

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle.

6 June 2022

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Discovery of a new synthetic tetrapeptide having luteinizing releasing hormone (LRH) activity

6 June 2022

25

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Plasma Growth Hormone Responses to Intrapituitary Injections of Growth Hormone Releasing Factor (GRF) in the Rat

6 June 2022

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Elevation of plasma radioimmunoassayable growth hormone in the rat induced by porcine hypothalamic extract.

6 June 2022

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibitory effect of somatostatin (SRIF) on the release of growth hormone (GH) induced in the rat by electrical stimulation.

6 June 2022

29

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

6 June 2022

31

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibition of insulin secretion by somatostatin

6 June 2022

32

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

6 June 2022

33

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Elevated Serum Prolactin Levels after Pituitary-Stalk Section in Man

6 June 2022

35

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture

6 June 2022

36

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Failure of reserpine to block ether-induced release of prolactin: physiological evidence that stress induced prolactin release is not caused by acute inhibition of PIF secretion.

6 June 2022

37

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The Preparation and Specificity of Antibody to Thyrotropin Releasing Hormone1

6 June 2022

38

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

A Radioimmunoassay for Gonadotropin-Releasing Hormone (Gn-RH) in Serum1

6 June 2022

Brain serotonin content: physiological dependence on plasma tryptophan levels.

39

0 references

42

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet

6 June 2022

43

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Elevation of plasma tryptophan by insulin in rat

6 June 2022

44

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of drugs on amines in the CNS.

6 June 2022

45

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade

6 June 2022

46

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Increased Plasma Levels of Growth Hormone During Infusion of Propranolol

6 June 2022

48

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man

6 June 2022

49

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Adrenergic receptor control mechanism for growth hormone secretion

6 June 2022

50

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Adrenergic control mechanism for vasopressin-induced plasma growth hormone response

6 June 2022

51

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Modification of hormonal responses to arginine by alpha-adrenergic blockade.

6 June 2022

52

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

6 June 2022

Q64917955

53

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Influence of Epinephrine-Propranolol Infusions on Growth Hormone Release in Normal and Hypopituitary Subjects

6 June 2022

54

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of propranolol on the response of serum growth hormone to glucagon

6 June 2022

55

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine

6 June 2022

56

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of aminophylline on the secretion of insulin, glucagon, luteinizing hormone and growth hormone in humans

6 June 2022

57

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism.

6 June 2022

58

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Stimulation of growth release by microinjection of norepinephrine into hypothalamus of baboons.

6 June 2022

60

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.

6 June 2022

61

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of reserpine on growth hormone response to insulin hypoglycaemia and to arginine infusion in normal subjects and hyperthyroid patients

6 June 2022

62

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of Chlorpromazine on Serum Growth-Hormone Concentration in Man

6 June 2022

63

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Stimulation of Human-Growth-Hormone Secretion by L-Dopa

6 June 2022

64

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Fusaric (5-Butylpicolinic) Acid: Its Effect on Plasma Growth Hormone

6 June 2022

66

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Prevention ofl-Dopa-Induced Growth Hormone Stimulation by Hyperglycemia

6 June 2022

67

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Growth hormone secretion during sleep

6 June 2022

68

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Experimental modification of the sleep-induced peak of growth hormone secretion.

6 June 2022

69

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibition of sleep related growth hormone release by elevated free fatty acids.

6 June 2022

70

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of lipids on growth hormone secretion in humans

6 June 2022

71

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Biogenic amines and the states of sleep

6 June 2022

72

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man

6 June 2022

73

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of Cyproheptadine on Human Growth Hormone Secretion

6 June 2022

0 references

Growth Hormone Regulation by Melatonin and Serotonin

75

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Absent sleep peak of growth hormone release in blind subjects: ccorrelation with sleep EEG stages.

20 January 2023

76

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Functional evaluation of prolactin secretion: a guide to therapy

20 January 2023

77

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Suppression of serum thyrotropin (TSH) by L-dopa in chronic hypothyroidism: interrelationships in the regulation of TSH and prolactin secretion

20 January 2023

79

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.

20 January 2023

82

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

20 January 2023

83

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Lactation following Therapeutic Abortion with Prostaglandin F2α

20 January 2023

85

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

20 January 2023

86

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

20 January 2023

87

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid

20 January 2023

88

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

20 January 2023

89

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations

20 January 2023

92

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Estrogen potentiation of phenothiazine-induced prolactin secretion in man

20 January 2023

93

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Actions of prolactin on human renal function

20 January 2023

94

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Utility ofl-dopa and Water Loading in Evaluation of Hyperprolactinemia

20 January 2023

95

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of 5-Hydroxytryptophan (5-HTP) on Plasma Prolactin Levels in Man

20 January 2023

96

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Elevation of Plasma TSH During Surgical Hypothermia

20 January 2023

97

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of cold exposure on serum thyrotropin.

20 January 2023

98

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release

20 January 2023

101

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of L-5-HTP on the Release of Growth Hormone, TSH and Insulin

20 January 2023

103

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Regulation of Human Gonadotropins: X. Episodic Fluctuation of LH During the Menstrual Cycle1

20 January 2023

104

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Repetitive luteinizing hormone elevations in serum of normal men

20 January 2023

105

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Rapid Cycling of Plasma Gonadotrophins in Normal Men as demonstrated by Frequent Sampling

20 January 2023

106

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms

20 January 2023

107

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man

20 January 2023

108

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Pulsatile Patterns of Gonadotropin Release in Subjects with and without Ovarian Function

20 January 2023

109

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The Biphasic Pattern in the Feedback Action of Ethinyl Estradiol on the Release of Pituitary FSH and LH*

20 January 2023

110

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Norepinephrine: turnover in rat brains after gonadectomy.

20 January 2023

113

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

A Method for Studying Norepinephrine and Serotonin Metabolism in Small Regions of Rat Brain: Effect of Ovariectomy on Amine Metabolism in Anterior and Posterior Hypothalamus

20 January 2023

114

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Increased turnover of 3H-norepinephrine in rat brain following castration or treatment with ovine follicle-stimulating hormone.

20 January 2023

115

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect ofl-DOPA on Testosterone and Luteinizing Hormone Production

20 January 2023

116

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Endocrine Effects of Pineal Gland and of Melatonin

20 January 2023

117

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

A psychoendocrine study of bereavement. I. 17-Hydroxycorticosteroid excretion rates of parents following death of their children from leukemia.

20 January 2023

120

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

A psychoendocrine study of bereavement. II. Observations on the process of mourning in relation to adrenocortical function.

20 January 2023

121

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of intraventricular administration of adrenergic drugs on the adrenal venous 17-hydroxycorticosteroid response to surgical stress in the dog.

20 January 2023

123

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of Diphenylhydantoin on Pituitary-Adrenal Interrelations

20 January 2023

126

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.

20 January 2023

127

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The effects of alcohol, barbiturate, and diazepam on hypothalamic-pituitary-adrenal function in chronic alcoholics.

20 January 2023

130

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibition of Hypoglycemia-Induced Cortisol Secretion by the Serotonin Antagonist Cyproheptadine

20 January 2023

132

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism

20 January 2023

133

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Growth Hormone Secretion in a Patient with Deprivation Dwarfism

20 January 2023

137

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Paradoxical hypersecretion of growth hormone in response to glucose.

20 January 2023

139

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Growth hormone dynamics in acromegaly

20 January 2023

140

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Acromegaly treated with chlorpromazine. A case study

20 January 2023

141

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Chlorpromazine treatment and growth hormone secretory responses in acromegaly

20 January 2023

142

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Suppressibility of Plasma Growth Hormone Levels in Acromegaly with Dexamethasone and Phentolamine1

20 January 2023

143

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibitory effect of L-Dopa on GH release in acromegalic patients

20 January 2023

144

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Abnormal serum growth hormone response to exercise in juvenile diabetics

20 January 2023

145

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

20 January 2023

146

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nerv

20 January 2023

147

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Functional Evaluation of Pituitary Reserve in Patients with the Amenorrhea-Galactorrhea Syndrome Utilizing Luteinizing Hormone-Releasing Hormone (LH-RH),l-Dopa and Chlorpromazine

20 January 2023

148

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibition of Prolactin Secretion and Successful Therapy of the Forbes-Albright Syndrome withl-Dopa*

20 January 2023

149

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Effect of Acute Administration of L-Dopa on Serum Concentrations of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in Patients with the Amenorrhea-Galactorrhea Syndrome

20 January 2023

150

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.

20 January 2023

151

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Prolactin, F.S.H., and L.H. in breast cancer: effect of levodopa and oophorectomy

20 January 2023

153

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

20 January 2023

155

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.

20 January 2023

156

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

Hypothalamic hypothyroidism

20 January 2023

157

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90023-2

20 January 2023

Identifiers

1 reference

28 August 2017

1 reference